ZA837789B - Cysteine-depleted muteins of biologically active proteins - Google Patents

Cysteine-depleted muteins of biologically active proteins

Info

Publication number
ZA837789B
ZA837789B ZA837789A ZA837789A ZA837789B ZA 837789 B ZA837789 B ZA 837789B ZA 837789 A ZA837789 A ZA 837789A ZA 837789 A ZA837789 A ZA 837789A ZA 837789 B ZA837789 B ZA 837789B
Authority
ZA
South Africa
Prior art keywords
cysteine
biologically active
active proteins
depleted muteins
muteins
Prior art date
Application number
ZA837789A
Other languages
English (en)
Inventor
F Mark David
Leo S Lin
Shi-Da Yu Lu
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ZA837789B publication Critical patent/ZA837789B/xx

Links

ZA837789A 1982-10-19 1983-10-19 Cysteine-depleted muteins of biologically active proteins ZA837789B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43515482A 1982-10-19 1982-10-19

Publications (1)

Publication Number Publication Date
ZA837789B true ZA837789B (en) 1984-11-28

Family

ID=23727220

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA837789A ZA837789B (en) 1982-10-19 1983-10-19 Cysteine-depleted muteins of biologically active proteins

Country Status (4)

Country Link
JP (4) JPS5993093A (enrdf_load_html_response)
IL (1) IL90047A (enrdf_load_html_response)
IN (1) IN161992B (enrdf_load_html_response)
ZA (1) ZA837789B (enrdf_load_html_response)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
EP0200748B1 (en) * 1984-10-15 1991-02-06 Cetus Corporation Human tumor necrosis factor
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
JP2583753B2 (ja) * 1984-12-21 1997-02-19 大塚製薬株式会社 抗腫瘍活性物質およびその製造法
JP2721854B2 (ja) * 1984-12-21 1998-03-04 大塚製薬株式会社 抗腫瘍活性物質
PT82429B (pt) * 1985-04-22 1988-03-03 Genentech Inc Novos mutantes do activador de plasmionogenio de tecido humano
US4818698A (en) * 1985-08-23 1989-04-04 Toyo Jozo Co., Ltd. Polypeptides and preparation process thereof
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
DK0383599T3 (da) * 1989-02-17 1996-08-05 Merck & Co Inc Protein-anticancermiddel
NZ232900A (en) * 1989-03-22 1993-08-26 Merck & Co Inc Pseudomonas exotoxin a, pe 40 domain derivatives
US6207798B1 (en) 1989-08-03 2001-03-27 Merck & Co., Inc. Modified PE40 toxin fusion proteins
JPH0751621A (ja) * 1993-08-12 1995-02-28 Kansei Kogyo Kk 静電吸着による管内面更生工法
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
KR20060034286A (ko) * 2003-07-11 2006-04-21 쉐링 악티엔게젤샤프트 개량된 재조합 인간 인터페론-베타-1ｂ 폴리펩티드
WO2021221470A1 (ko) * 2020-04-29 2021-11-04 (주) 제노팜 인터페론-베타 변이체와 항체가 융합된 재조합 단백질 및 이를 포함하는 약학 조성물

Also Published As

Publication number Publication date
JPS6128394A (ja) 1986-02-08
JPH0380475B2 (enrdf_load_html_response) 1991-12-25
IL90047A (en) 1992-12-01
JPS6128384A (ja) 1986-02-08
IN161992B (enrdf_load_html_response) 1988-03-12
JPS6128393A (ja) 1986-02-08
JPH057996B2 (enrdf_load_html_response) 1993-01-29
JPS5993093A (ja) 1984-05-29
JPS6357440B2 (enrdf_load_html_response) 1988-11-11

Similar Documents

Publication Publication Date Title
EP0210461A3 (en) Physiologically active polypeptide buf-3
AU5518086A (en) Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins
ZA837789B (en) Cysteine-depleted muteins of biologically active proteins
HUT46539A (en) Biologically active copolimers
IT1167607B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
GB2177919B (en) Synergistic biologically active substances
DE3377654D1 (en) Hypocholesterolemically active protein
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
IL75828A (en) Immobilization by biologically active proteins
IT1170302B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
IT1164861B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
AU557783B2 (en) Biologically active peptides
GB8919310D0 (en) Biologically active substances
GB8300998D0 (en) Derivatives of biologically active substituted tin compounds
IE830105L (en) Preparation of optically active mercaptoalkanoylaminoacids
DE3264659D1 (en) Biologically active peptides
GB2086396B (en) Biologically active peptides
IL90047A0 (en) Cysteine-depleted muteins of biologically active proteins
GB8309547D0 (en) Biologically active peptides
DE3361316D1 (en) Preparation of optically active 4-demethoxydaunomycinone
IE832922L (en) Obtaining biologically active protein¹¹heterologous proteins
JPS5668651A (en) Novel biologically active peptide
EP0253245A3 (en) Biologically active peptides tan-866
GB8313637D0 (en) Preparation of 3 3-/3 4-diaminodiphenylmethane
GB8413272D0 (en) Biologically active tridecapeptides